Trial Profile
A retrospective study of Ocriplasmin treatment for vitreomacular traction in real life
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Jan 2018
Price :
$35
*
At a glance
- Drugs Ocriplasmin (Primary)
- Indications Retinal disorders
- Focus Adverse reactions; Therapeutic Use
- 22 Jan 2018 New trial record